Publication | Closed Access

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI

Egfr TkiSensitive Egfr MutationMedicineReceptor Tyrosine KinasePathologyBronchial NeoplasmTyrosine Kinase InhibitorsOncologyRadiation OncologyLung Cancer